EBD Device Leader: Cynosure Lutronic’s XERF

Cynosure Lutronic’s XERF has crossed 300 contracts. This milestone occurred just 11 months after the product’s launch and signals a growth in demand for XERF, a key player in the EBD market. You can explore more about this device’s capabilities and its impact on the market.

Understanding XERF’s Innovative Approach

XERF stands for “monopolar radiofrequency (RF) medical device”. It stands out as a cutting-edge innovation in medical technology. Developed strategically by Cynosure and Lutronic following their merger, XERF gathers their technological expertise into one device.

Key Features of XERF

• Dual Monopolar Technology: Adds a 2MHz frequency to the 6.78MHz, allowing three depth adjustments.
• Spaider Pattern Technology: Covers maximum size of 20X30mm, targeting larger areas per shot.
• Cooling Gas Integration: Allows procedures without anesthesia.

This technology shows the commitment of Cynosure Lutronic to push boundaries in medical device innovation.

Global Market Move

Cynosure Lutronic aims to capture more of the global market using their growth in Korea as leverage. They are seeking market approvals in various regions like Asia-Pacific, North America, and Europe. Their presence in the U.S. and their strategic positioning in key markets showcase their ambition.

• Market Presence: Headquarters in Massachusetts, activity in North America, Europe, and Asia-Pacific.
• Regulatory Approvals: Pursuing medical device approvals globally.

Merging Strengths for Global Leadership

Cynosure Lutronic’s merger involved merging two industry leaders, resulting in a powerful synergy. This move is expected to boost their relevance in the industry.

Benefits of the Merger

• Combined Experience: Over 30 years of collective knowledge in medical devices.
• Diverse Product Portfolio: Includes Derma V, Clarity II, Hollywood Spectra, and Picosure Pro.

They confirm their determination to enhance their market influence through strategic R&D investments.

Expanding Product Range with Mosaic 3D

Cynosure Lutronic doesn’t stop their growth with XERF. They’ve announced the release of Mosaic 3D, a non-invasive laser device using 1550nm Er: Glass laser, which is cleared in several countries, including the U.S. and South Korea.

• Key Features: Non-invasive fractional laser with 1550nm wavelength.
• Market Approval: Cleared in U.S., South Korea, Philippines, Israel, and more.

Conclusion

With the XERF device, Cynosure Lutronic is benchmarking a shift in medical technology markets. Their dual monopolar technology revolutionizes procedures, setting a higher standard for efficiency. Their global market aspirations and diversity in product portfolios further affirm their leadership position in the EBD field. Keep an eye on their advancements for shifts in the medical technology industry.